HealthEquity (HQY) Tops Q3 EPS by 4c, Beats on Revenues; Lowers FY18 EPS Mid-Point Guidance Below Consensus, FY18 Revenue Mid-Point Below Estimates

HealthEquity (NASDAQ: HQY) reported Q3 EPS of $0.17, $0.04 better than the analyst estimate of $0.13. Revenue for the quarter came in at $56.8 million versus the consensus estimate of $55.41 million.

GUIDANCE:

HealthEquity sees Q4 2018 EPS of $0.64-$0.66, versus the consensus of $0.71. HealthEquity sees Q4 2018 revenue of $225-228 million, versus the consensus of $227 million.

For earnings history and earnings-related data on HealthEquity (HQY) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Associated Banc-Corp (ASB) Tops Q1 EPS by 3c
• Carlisle Cos. (CSL) Tops Q1 EPS by 91c, Beats on Revenue; Offers FY24 Outlook